tldrdailynews.com logo

Vistagen's Social Anxiety Nasal Spray Trial Sends Stock Price Soaring

1 min read
Source: Endpoints News
Vistagen's Social Anxiety Nasal Spray Trial Sends Stock Price Soaring
Photo: Endpoints News
TL;DR

San Francisco-based pharmaceutical company Vistagen experienced a surge in its stock price of over 1,000% after announcing positive results from a Phase III trial for its nasal spray in treating social anxiety disorder. The trial demonstrated statistically significant differences in subjective distress scores and clinician-assessed responders between the experimental drug and placebo.

Topics:businesspharmaceuticals#nasal-spray#pharmaceuticals#phase-iii-trial#social-anxiety#stock-price#vistagen
Share this article
  1. Vistagen's positive PhIII for social anxiety nasal spray pushes stock price up 1000+%  Endpoints News
  2. Biotech Firm Vistagen Surges 1,370% on Social Anxiety Spray Trial Success  Yahoo Finance
  3. Vistagen stock soars 1,272% on social anxiety spray data  FierceBiotech
  4. Vistagen (NASDAQ:VTGN) Skyrockets over 600% on Positive Phase 3 Data for Social Anxiety Disorder - TipRanks.com  TipRanks
  5. VistaGen Therapeutics (VTGN Stock) Exploded 3,471% Here’s Why  Penny Stocks
  6. View Full Coverage on Google News

Want the full story? Read the original reporting

Read on Endpoints News